staurosporine aglycone has been researched along with Ovarian Neoplasms in 1 studies
staurosporine aglycone: metabolite from culture broth of Nocardiopsis sp.; a neurotrophin antag; inhibits BDNF TrkB receptor
Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.
Excerpt | Relevance | Reference |
---|---|---|
"MTT assays showed that the ovarian cancer cell line SK-OV-3 cells were sensitive to the growth inhibitory effect of K252a." | 1.33 | K252a inhibits proliferation of ovarian cancer cells by upregulating p21WAF1. ( Fukuda, J; Miyakawa, I; Nasu, K; Nishida, M; Takai, N; Ueda, T, 2005) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Takai, N | 1 |
Ueda, T | 1 |
Nishida, M | 1 |
Nasu, K | 1 |
Fukuda, J | 1 |
Miyakawa, I | 1 |
1 other study available for staurosporine aglycone and Ovarian Neoplasms
Article | Year |
---|---|
K252a inhibits proliferation of ovarian cancer cells by upregulating p21WAF1.
Topics: Blotting, Western; Carbazoles; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation | 2005 |